These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 2072580)

  • 1. Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo.
    Maeda N; Muta H; Oflazoglu E; Yoshikai Y
    Cancer Sci; 2010 Jan; 101(1):224-30. PubMed ID: 19799612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
    Nagasaki M; Zhang J; Morikawa S; Harada T; Nabika T; Tanaka Y
    Pathol Int; 2005 May; 55(5):264-72. PubMed ID: 15871724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, release, and characterization of soluble human T-lymphotropic virus-I (HTLV-I) antigens from an infected cell line.
    Olsen RG; Lewis MG; Bauer RM; Tarr MJ; Mathes LE; Lafrado LJ; Blakeslee JR
    Cancer Detect Prev; 1988; 12(1-6):31-7. PubMed ID: 3180135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Production of monoclonal antibodies to human T-cell lymphotropic virus type 1 (HTLV-1) and studies of their specificity].
    Iwatsuki K; Jin FX; Takigawa M; Sugaya K; Yamada M
    Nihon Hifuka Gakkai Zasshi; 1989 Sep; 99(10):1059-65. PubMed ID: 2607667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-I-infected T cells activate autologous CD4+ T cells susceptible to HTLV-I infection in a costimulatory molecule-dependent fashion.
    Takamoto T; Makino M; Azuma M; Kanzaki T; Baba M; Sonoda S
    Eur J Immunol; 1997 Jun; 27(6):1427-32. PubMed ID: 9209495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
    Iwanaga M; Takada K; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T; Mikuni C; Maekawa I; Miyazaki T
    In Vivo; 1994; 8(6):1007-10. PubMed ID: 7772727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Localization of HTLV-I-associated antigens in adult T cell leukemia cells and HTLV-I-infected cell line cells].
    Jin FX; Iwatsuki K; Horiguchi D; Sugaya K; Nakayama F; Koide M; Takigawa M; Yamada M
    Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):89-95. PubMed ID: 2072580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune suppression in HTLV-I carriers: a predictive sign of adult T-cell leukemia.
    Taguchi H; Miyoshi I
    Acta Med Okayama; 1989 Dec; 43(6):317-21. PubMed ID: 2696327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell adhesion molecules in HTLV-I infection.
    Uchiyama T; Ishikawa T; Imura A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S114-8. PubMed ID: 8797713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD45RO expression on peripheral lymphocytes as a prognostic marker for adult T-cell leukemia.
    Suzuki M; Matsuoka H; Yamashita K; Maeda K; Kawano K; Uno H; Tsubouchi H
    Leuk Lymphoma; 1998 Feb; 28(5-6):583-90. PubMed ID: 9613989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interleukin-2 receptor: a target for immunotherapy.
    Waldmann TA; Goldman C; Top L; Grant A; Burton J; Bamford R; Roessler E; Horak I; Zaknoen S; Kasten-Sportes C
    Ann N Y Acad Sci; 1993 Jun; 685():603-10. PubMed ID: 8363269
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor necrosis factor-beta and hypercalcemia.
    Ishibashi K; Kodama M; Hanada S; Arima T
    Leuk Lymphoma; 1992 Aug; 7(5-6):409-17. PubMed ID: 1493442
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.